Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)
Titel:
Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)
Auteur:
Kawashima, Hideyuki Tomaniak, Mariusz Ono, Masafumi Wang, Rutao Hara, Hironori Gao, Chao Takahashi, Kuniaki Sharif, Faisal Thury, Attila Suryapranata, Harry Walsh, Simon Cotton, James Carrie, Didier Sabate, Manel Steinwender, Clemens Leibundgut, Gregor Wykrzykowska, Joanna de Winter, Robbert J. Garg, Scot Hamm, Christian Steg, Philippe Gabriel Jüni, Peter Vranckx, Pascal Valgimigli, Marco Windecker, Stephan Onuma, Yoshinobu Serruys, Patrick W.